There are studies suggesting that genetics may affect the susceptibility to ICDs in patients on cabergoline; for example, a study found that the prevalence of the DRD3 p.Ser9Gly (rs6280) CT genotype in Indian patients with Parkinsonism is a risk factor for developing ICDs [23]. The gene discussed is DRD3; the disease is Parkinsonism.